FDA Investigator: Patricia F. Hughes Troost

- Patricia F. Hughes Troost first started conducting FDA inspections in 2005, with the last inspection in 2022. Over that time, Patricia F. Hughes Troost has conducted 24 inspections at 23 companies across 21 sites.

Get Patricia Hughes Troost's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 United Therapeutics Corporation, Silver Spring | 2014

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483

FDA 483 Bristol-Myers Squibb Co., Inc., East Syracuse | 2013

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483

FDA 483 Novartis Pharmaceuticals Corporation, Vacaville | 2012

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483

FDA 483 AbbVie Research Bioresearch Center, Worcester | 2011

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483

FDA 483 Genzyme Flanders N.v., Geel | 2009

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483

FDA 483 Bio-Technology General (Israel), Ltd., Kiryat Malchi | 2009

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483

FDA 483 Novartis Pharma AG, Basel | 2009

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483

FDA 483 MicroSafe Laboratories, Leiden | 2009

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483

FDA 483 Janssen Biologics B.V., Leiden | 2009

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483

FDA 483 Chugai Pharma Manufacturing Co. Ltd., Utsunomiya-shi | 2008

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483

FDA 483 GlaxoSmithKline LLC, Conshohocken | 2007

Out-of-stock
Patricia F. Hughes Troost
Human Drug Form 483